BE1003093A3 - Procede de preparation d'une composition pharmaceutique sous forme de microparticules. - Google Patents

Procede de preparation d'une composition pharmaceutique sous forme de microparticules. Download PDF

Info

Publication number
BE1003093A3
BE1003093A3 BE9000729A BE9000729A BE1003093A3 BE 1003093 A3 BE1003093 A3 BE 1003093A3 BE 9000729 A BE9000729 A BE 9000729A BE 9000729 A BE9000729 A BE 9000729A BE 1003093 A3 BE1003093 A3 BE 1003093A3
Authority
BE
Belgium
Prior art keywords
preparation
microparticles
pharmaceutical composition
extrusion
composition
Prior art date
Application number
BE9000729A
Other languages
English (en)
Inventor
Piero Orsolini
Original Assignee
Debio Rech Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debio Rech Pharma Sa filed Critical Debio Rech Pharma Sa
Application granted granted Critical
Publication of BE1003093A3 publication Critical patent/BE1003093A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

On prèpare une composition pharmaceutique se présentant sous forme de microparticules d'un copolymère d'acide lactique et glycolique incorporant à titre de substance active un pamoate, tannate, stéarate ou palmitate d'un peptide naturel ou synthétique comprenant de 3 à 45 acides aminés, tel que le LH-RH, la somatostatine, le GR-RH ou la calcitonine ou de l'un de leurs analogues ou homologues synthétiques. La préparation comprend le mélange à sec des ingrédients, sous forme pulvérulente, la précompression et le préchauffage du mélange suivis d'une extrusion du mélange précomprimé et préchauffé. Le produit résultant de l'extrusion est ensuite pulvérisé et finalement tamisé. La composition s'utilise pour la préparation de suspension injectables.
BE9000729A 1989-07-28 1990-07-18 Procede de preparation d'une composition pharmaceutique sous forme de microparticules. BE1003093A3 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH2829/89A CH679207A5 (fr) 1989-07-28 1989-07-28

Publications (1)

Publication Number Publication Date
BE1003093A3 true BE1003093A3 (fr) 1991-11-19

Family

ID=4242536

Family Applications (1)

Application Number Title Priority Date Filing Date
BE9000729A BE1003093A3 (fr) 1989-07-28 1990-07-18 Procede de preparation d'une composition pharmaceutique sous forme de microparticules.

Country Status (23)

Country Link
US (1) US5134122A (fr)
JP (1) JPH0662427B2 (fr)
AT (1) AT397197B (fr)
AU (1) AU619996B2 (fr)
BE (1) BE1003093A3 (fr)
CA (1) CA2021767C (fr)
CH (1) CH679207A5 (fr)
DE (1) DE4023134C2 (fr)
DK (1) DK175495B1 (fr)
ES (1) ES2020890A6 (fr)
FI (1) FI97688C (fr)
FR (1) FR2650182B1 (fr)
GB (1) GB2234169B (fr)
GR (1) GR1001215B (fr)
IE (1) IE65397B1 (fr)
IL (1) IL95120A (fr)
IT (1) IT1243357B (fr)
LU (1) LU87772A1 (fr)
NL (1) NL194858C (fr)
NO (1) NO300304B1 (fr)
PT (1) PT94842B (fr)
SE (1) SE504279C2 (fr)
ZA (1) ZA905654B (fr)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5538739A (en) * 1989-07-07 1996-07-23 Sandoz Ltd. Sustained release formulations of water soluble peptides
PH30995A (en) * 1989-07-07 1997-12-23 Novartis Inc Sustained release formulations of water soluble peptides.
CH681425A5 (fr) * 1990-11-14 1993-03-31 Debio Rech Pharma Sa
WO1991017772A1 (fr) * 1990-05-16 1991-11-28 Southern Research Institute Dopamine administree par liberation regulee et son utilisation pour stimuler la croissance de fibres nerveuses
US6517859B1 (en) 1990-05-16 2003-02-11 Southern Research Institute Microcapsules for administration of neuroactive agents
CH683149A5 (fr) * 1991-07-22 1994-01-31 Debio Rech Pharma Sa Procédé pour la préparation de microsphères en matériau polymère biodégradable.
US5470582A (en) * 1992-02-07 1995-11-28 Syntex (U.S.A.) Inc. Controlled delivery of pharmaceuticals from preformed porous polymeric microparticles
US5876452A (en) * 1992-02-14 1999-03-02 Board Of Regents, University Of Texas System Biodegradable implant
US6013853A (en) * 1992-02-14 2000-01-11 The University Of Texas System Continuous release polymeric implant carrier
GB9211268D0 (en) * 1992-05-28 1992-07-15 Ici Plc Salts of basic peptides with carboxyterminated polyesters
US5456917A (en) * 1993-04-12 1995-10-10 Cambridge Scientific, Inc. Method for making a bioerodible material for the sustained release of a medicament and the material made from the method
CA2178592C (fr) * 1993-12-09 2009-07-28 Zentaris Gmbh Suspensions pour injection a action prolongee et procede de preparation
DE4342092B4 (de) * 1993-12-09 2007-01-11 Zentaris Gmbh Langwirkende Injektionssuspension und Verfahren zur Herstellung
US5569468A (en) * 1994-02-17 1996-10-29 Modi; Pankaj Vaccine delivery system for immunization, using biodegradable polymer microspheres
US5417982A (en) * 1994-02-17 1995-05-23 Modi; Pankaj Controlled release of drugs or hormones in biodegradable polymer microspheres
US5430021A (en) * 1994-03-18 1995-07-04 Pharmavene, Inc. Hydrophobic drug delivery systems
US5595760A (en) * 1994-09-02 1997-01-21 Delab Sustained release of peptides from pharmaceutical compositions
FR2748205A1 (fr) 1996-05-06 1997-11-07 Debio Rech Pharma Sa Compositions pharmaceutiques pour la liberation controlee de principes actifs insolubles
US5945128A (en) * 1996-09-04 1999-08-31 Romano Deghenghi Process to manufacture implants containing bioactive peptides
EP0930874A2 (fr) * 1996-10-09 1999-07-28 Takeda Chemical Industries, Ltd. Procede de production d'une microparticule
WO1998032423A1 (fr) * 1997-01-29 1998-07-30 Takeda Chemical Industries, Ltd. Microspheres a liberation prolongee, leur production et utilisation
US6071982A (en) * 1997-04-18 2000-06-06 Cambridge Scientific, Inc. Bioerodible polymeric semi-interpenetrating network alloys for surgical plates and bone cements, and method for making same
AU1384199A (en) 1997-11-07 1999-05-31 Chiron Corporation Method for producing igf-1 sustained-release formulations
IT1304152B1 (it) * 1998-12-10 2001-03-08 Mediolanum Farmaceutici Srl Composizioni comprendenti un peptide ed acido polilattico-glicolicoatte alla preparazione di impianti sottocutanei aventi un prolungato
US6455526B1 (en) 1998-12-16 2002-09-24 Aventis Pharmaceuticals, Inc. Biodegradable polymer encapsulated pharmaceutical compositions and method for preparing the same
ATE303795T1 (de) * 1998-12-16 2005-09-15 Aventis Pharma Inc In biologisch abbaubare polymere eingekapselter serotoninrezeptor-antagonist und deren herstellungsverfahren
EP1156781B1 (fr) 1999-02-26 2005-06-08 Chiron Corporation Microemulsions avec des macromolecules adsorbees et microparticules
US7713739B1 (en) * 2000-11-17 2010-05-11 Novartis Vaccines And Diagnostics, Inc. Microparticle-based transfection and activation of dendritic cells
ES2169980B1 (es) 1999-12-17 2003-11-01 Lipotec Sa Microcapsulas para la liberacion prolongada de farmacos.
US6362308B1 (en) 2000-08-10 2002-03-26 Alkermes Controlled Therapeutics Inc. Ii Acid end group poly(d,l-lactide-co-glycolide) copolymers high glycolide content
NZ528994A (en) * 2001-04-26 2006-02-24 Control Delivery Sys Inc Sustained release drug delivery system containing codrugs
US20040022853A1 (en) * 2001-04-26 2004-02-05 Control Delivery Systems, Inc. Polymer-based, sustained release drug delivery system
US8501056B2 (en) * 2001-05-23 2013-08-06 Hexal Ag Homogenized product for implants and microparticles
WO2003000156A1 (fr) 2001-06-22 2003-01-03 Southern Biosystems, Inc. Implants coaxiaux a liberation prolongee d'ordre 0
IN2014DN10834A (fr) * 2001-09-17 2015-09-04 Psivida Inc
KR101041767B1 (ko) * 2002-06-25 2011-06-17 다케다 야쿠힌 고교 가부시키가이샤 서방성 조성물의 제조 방법
EP1911763B1 (fr) 2003-01-28 2010-08-11 Ironwood Pharmaceuticals, Inc. Compositions pour le traitement de troubles gastrointestinaux
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
GB0304726D0 (en) * 2003-03-01 2003-04-02 Ardana Bioscience Ltd New Process
MXPA05011299A (es) * 2003-04-30 2006-01-24 Debiopharm Sa Metodos y composiciones utilizando la hormona liberadora de la hormona gonadotropina.
US9149440B2 (en) * 2003-09-02 2015-10-06 University Of South Florida Nanoparticles for drug-delivery
CA2544678C (fr) 2003-11-05 2013-12-31 Sunesis Pharmaceuticals, Inc. Modulateurs de l'adhesion cellulaire
WO2005063276A1 (fr) * 2003-12-23 2005-07-14 Debiopharm S.A. Procedes et compositions faisant appel a la gonadoliberine
FR2865938B1 (fr) * 2004-02-05 2006-06-02 Sod Conseils Rech Applic Formulation retard solide comprenant de l'acetate de triptoreline
WO2006078320A2 (fr) 2004-08-04 2006-07-27 Brookwood Pharmaceuticals, Inc. Procede de production de systemes d'administration, et systemes d'administration
AU2005279772A1 (en) 2004-08-30 2006-03-09 Spineovations, Inc. Method of treating spinal internal disk derangement
EP1674082A1 (fr) * 2004-12-22 2006-06-28 Zentaris GmbH Procédé pour la manufacture des suspensions ou lyophilisates steriles des complexes mal-soluble de peptides basic, des formulations pharmaceutiques avec ces complexes et leur utilisation comme medicament
DK2444079T3 (en) 2005-05-17 2017-01-30 Sarcode Bioscience Inc Compositions and Methods for the Treatment of Eye Diseases
KR100722607B1 (ko) 2006-05-11 2007-05-28 주식회사 펩트론 분산성 및 주사 투여능이 향상된 서방성 미립구의 제조방법
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
JP5419169B2 (ja) * 2007-06-06 2014-02-19 デビオファーム リサーチ アンド マニュファクチャリング ソシエテ アノニム 微小粒子で構成される徐放性医薬組成物
ES2830024T3 (es) 2007-10-19 2021-06-02 Novartis Ag Composiciones y métodos para el tratamiento del edema macular
WO2009085952A1 (fr) 2007-12-20 2009-07-09 Brookwood Pharmaceuticals, Inc. Procédé pour préparer des microparticules ayant un faible volume de solvant résiduel
US8469961B2 (en) * 2008-03-05 2013-06-25 Neville Alleyne Methods and compositions for minimally invasive capsular augmentation of canine coxofemoral joints
US20100010549A1 (en) * 2008-03-05 2010-01-14 Neville Alleyne device and method of minimally invasive extracapsular ligamentous augmentation for canine stifle ligament injuries
WO2009139817A2 (fr) 2008-04-15 2009-11-19 Sarcode Corporation Produit pharmaceutique cristallin et ses procédés de préparation et d'utilisation
WO2009128932A1 (fr) * 2008-04-15 2009-10-22 Sarcode Corporation Administration d'antagonistes de lfa-1 au système gastro-intestinal
ES2522968T3 (es) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
CA2759807C (fr) * 2009-04-23 2018-03-20 Sustained Nano Systems Llc Dispositif d'administration a liberation controlee
WO2011050175A1 (fr) 2009-10-21 2011-04-28 Sarcode Corporation Agent pharmaceutique cristallin et procédés de préparation et utilisation de celui-ci
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
KR101411349B1 (ko) 2010-12-24 2014-06-25 주식회사 삼양바이오팜 생리활성 펩타이드를 포함하는 마이크로입자 및 그의 제조방법, 및 그를 포함하는 약제학적 조성물
WO2012151343A1 (fr) 2011-05-04 2012-11-08 Balance Therapeutics, Inc. Dérivés de pentylènetétrazole
EP2630964A1 (fr) 2012-02-22 2013-08-28 Immundiagnostik AG Procédé et médicament pour traiter des patients souffrant de prédiabète et diabètes de type 2
TWI636799B (zh) * 2012-05-14 2018-10-01 日商帝人股份有限公司 滅菌組成物
KR20200108932A (ko) 2012-07-25 2020-09-21 에스에이알코드 바이오사이언스 인코포레이티드 Lfa-1 저해제 및 그의 다형체
WO2014131024A2 (fr) 2013-02-25 2014-08-28 Synergy Pharmaceuticals Inc. Agonistes de la guanylate cyclase et applications associées
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
AU2014235215A1 (en) 2013-03-15 2015-10-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CA2926358A1 (fr) * 2013-10-08 2015-04-16 Ferring B.V. Microparticules comprenant l'hormone de liberation des gonadotropines gnrh produites a partir d'une solution saturee en gaz ou pgss
JP6661531B2 (ja) 2013-10-10 2020-03-11 シナジー ファーマシューティカルズ インコーポレイテッド オピオイド誘発性機能障害の治療に有用なグアニル酸シクラーゼのアゴニスト
WO2016115532A1 (fr) 2015-01-16 2016-07-21 Spineovations, Inc. Procédé de traitement de disque vertébral
US10653744B2 (en) 2016-01-11 2020-05-19 Bausch Health Ireland Limited Formulations and methods for treating ulcerative colitis
AU2018300071B2 (en) 2017-07-11 2024-09-19 Sustained Nano Systems Llc Radiation sterilization of hypercompressed polymer dosage forms
CA3069159A1 (fr) 2017-07-11 2019-01-17 Sustained Nano Systems Llc Formulations pharmaceutiques hydrocompressees
US11052046B2 (en) 2017-09-26 2021-07-06 Nanomi B.V. Method for preparing micro-particles by double emulsion technique
WO2021185373A1 (fr) * 2020-03-20 2021-09-23 苏州医本生命科技有限公司 Microparticule pour chargement de médicament, microparticule de chargement de médicament, tube contenant des particules et système d'implantation pour microparticule
US12611313B2 (en) 2023-04-06 2026-04-28 33 Medical, Inc. Minimally invasive compliant devices for total lumbar disc replacement
KR20260021016A (ko) 2023-06-02 2026-02-12 33 메디칼, 인크. 추간판성 통증의 치료를 위한 조성물, 및 그의 제조 및 사용 방법
WO2026050206A1 (fr) 2024-08-27 2026-03-05 Ironwood Pharmaceuticals, Inc. Combinaisons d'agonistes du récepteur de glp-1 et de guanylate cyclase c (gc-c)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60181029A (ja) * 1984-02-29 1985-09-14 Toyo Jozo Co Ltd 徐放性製剤の製法
FR2620621A1 (fr) * 1987-09-21 1989-03-24 Bpd Biopharm Dev Ltd Composition pharmaceutique pour la liberation soutenue et controlee de polypeptides insolubles dans l'eau

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3976071A (en) * 1974-01-07 1976-08-24 Dynatech Corporation Methods of improving control of release rates and products useful in same
US3978203A (en) * 1974-07-12 1976-08-31 Dynatech Corporation Sustained release of pharmaceuticals from polyester matrices
US4107288A (en) * 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
US4010125A (en) * 1975-06-12 1977-03-01 Schally Andrew Victor [D-Trp6 ]-LH-RH and intermediates therefor
US4622244A (en) * 1979-09-04 1986-11-11 The Washington University Process for preparation of microcapsules
PH19942A (en) * 1980-11-18 1986-08-14 Sintex Inc Microencapsulation of water soluble polypeptides
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
US4349530A (en) * 1980-12-11 1982-09-14 The Ohio State University Implants, microbeads, microcapsules, preparation thereof and method of administering a biologically-active substance to an animal
US4483807A (en) * 1981-01-27 1984-11-20 Japan Atomic Energy Research Institute Process for producing a slow release composite
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
CH661206A5 (fr) * 1983-09-23 1987-07-15 Debiopharm Sa Procede pour la preparation d'un medicament destine au traitement de maladies hormonodependantes.
US4666704A (en) * 1985-05-24 1987-05-19 International Minerals & Chemical Corp. Controlled release delivery system for macromolecules
IL79134A (en) * 1985-07-29 1991-06-10 American Cyanamid Co Continuous release peptide implants for parenteral administration
US4962091A (en) * 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides
JPS63218632A (ja) * 1987-03-06 1988-09-12 Japan Atom Energy Res Inst ホルモンに徐放性機能を付与した生体分解型コポリ（グルコ−ル酸／ｌ−乳酸）複合体の製造方法
US4897268A (en) * 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
DE3734223A1 (de) * 1987-10-09 1989-04-20 Boehringer Ingelheim Kg Implantierbares, biologisch abbaubares wirkstofffreigabesystem

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60181029A (ja) * 1984-02-29 1985-09-14 Toyo Jozo Co Ltd 徐放性製剤の製法
FR2620621A1 (fr) * 1987-09-21 1989-03-24 Bpd Biopharm Dev Ltd Composition pharmaceutique pour la liberation soutenue et controlee de polypeptides insolubles dans l'eau

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PROC. NATL. ACAD. SCI. USA, vol. 85, no. 15, August 1988, pages 5688-5692; M. MASON-GARCIA et al.: "Radioimmunoassay for octapeptide analogs of somatostatin: Measurement of serum levels after administration of long-acting microcapsule formulations" *
WPIL FILE SUPPLIER, accession no. 85-267444 [43], Derwent Publications Ltd, London, GB; & JP-A-60 181 029 (TOYO JOZO K.K. et al.) 14-09-1985 *

Also Published As

Publication number Publication date
NO903264L (no) 1991-01-29
GB2234169B (en) 1993-02-10
ES2020890A6 (es) 1991-10-01
PT94842B (pt) 1997-04-30
NL9001646A (nl) 1991-02-18
FR2650182B1 (fr) 1992-05-15
PT94842A (pt) 1991-03-20
ZA905654B (en) 1991-05-29
FR2650182A1 (fr) 1991-02-01
JPH0366625A (ja) 1991-03-22
DE4023134C2 (de) 1997-04-17
SE9002522L (sv) 1991-01-29
ATA154590A (de) 1993-07-15
NL194858C (nl) 2003-05-06
NO300304B1 (no) 1997-05-12
DE4023134A1 (de) 1991-01-31
GR1001215B (el) 1993-06-21
GR900100568A (en) 1991-12-10
IT1243357B (it) 1994-06-10
IE902592A1 (en) 1991-02-27
LU87772A1 (fr) 1990-12-11
AT397197B (de) 1994-02-25
CA2021767C (fr) 1996-10-22
FI97688C (fi) 1997-02-10
US5134122A (en) 1992-07-28
SE504279C2 (sv) 1996-12-23
NO903264D0 (no) 1990-07-23
FI97688B (fi) 1996-10-31
GB9015722D0 (en) 1990-09-05
FI903643A0 (fi) 1990-07-19
IT9021019A1 (it) 1992-01-23
GB2234169A (en) 1991-01-30
IE65397B1 (en) 1995-10-18
DK180790D0 (da) 1990-07-27
CA2021767A1 (fr) 1991-01-29
JPH0662427B2 (ja) 1994-08-17
DK175495B1 (da) 2004-11-08
AU5910390A (en) 1991-01-31
IL95120A (en) 1994-10-07
CH679207A5 (fr) 1992-01-15
SE9002522D0 (sv) 1990-07-27
AU619996B2 (en) 1992-02-06
DK180790A (da) 1991-01-29
IT9021019A0 (it) 1990-07-23
IL95120A0 (en) 1991-06-10
NL194858B (nl) 2003-01-06

Similar Documents

Publication Publication Date Title
BE1003093A3 (fr) Procede de preparation d'une composition pharmaceutique sous forme de microparticules.
DE59207523C5 (de) Verfahren zur herstellung von humanproteinhaltigen, konservierten arzneimitteln für infusions- oder injektionszwecke
DE69731957T2 (de) Orale pharmazeutische produkte mit peptiden
AU623610B2 (en) A free-flowing granular composition containing ibuprofen and a method for its preparation
EP0251459B1 (fr) Composition pharmaceutique à libération contrôlée
US6399103B1 (en) Method of producing a sustained-release preparation
US6011011A (en) Sustained-release protein formulations
IE861813L (en) New Polysaccharide Esters and their Salts
EP0423484B1 (fr) Comprimé à libération retardée
DE3345314A1 (de) Oligomere hydroxycarbonsaeurederivate, deren herstellung und verwendung
KR890003400A (ko) 경비(經鼻)투여용 생리 활성 펩티드 분말 조성물(제제)
YU46701B (sh) Postupak u za dobijanje osnovnog nosećeg materijala za dozne oblike lekova sa produženim izdvajanjem aktivne supstance
GB2237510B (en) Small particle drug compositions for nasal administration
IE863420L (en) Xanthan gum sustained drug release composition
CA2009890A1 (fr) Acide valproique
PT85591A (en) Process for the preparation of multiple unit dosage pharmaceutical compositions comprising as a pharmaceutilly active compound l-dopa
DE69838647T2 (de) Behandlung von fettleibigkeit
NL8802274A (nl) Zetpillen.
DE69719083T2 (de) Neuartige orale Zubereitungen von Calcitonin
EP0402186A3 (fr) Procédé de fabrication d'un amidon directement compressible en vue de l'utilisation dans la fabrication de comprimés et comprimés obtenus
DE3913350A1 (de) Saeureadditionssalze aus amidiertem taurin oder glycin, deren herstellung und verwendung
CA1203480A (fr) Produits comprimes, avec degagement retarde du pricipe actif
GB1458414A (en) Composition and method of treatin ulcers
US20010002263A1 (en) Complex of human growth hormone and zinc and use
EP0249811B1 (fr) Composition pharmaceutique administrable par voie parentérale contenant une calcitonine comme substance active

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: S.A. *DEBIO RECHERCHE PHARMACEUTIQUE

Effective date: 20100718